D R Johns Lab Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.77 Cr
as on 07-07-2024
- Satisfied Charges ₹ 1.11 Cr
as on 07-07-2024
- Revenue 11.24%
(FY 2023)
- Profit 119.31%
(FY 2023)
- Ebitda -12.15%
(FY 2023)
- Net Worth 11.01%
(FY 2023)
- Total Assets 11.54%
(FY 2023)
About D R Johns Lab Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.77 Cr. The company has closed loans amounting to ₹1.11 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at D R Johns Lab Pharma Private Limited India is Ramnish Sharma as CEO. Anita Sharma and Shyam Chandra serve as directors at the Company.
- CIN/LLPIN
U24232DL2010PTC203412
- Company No.
203412
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does D R Johns Lab Pharma Private Limited offer?
D R Johns Lab Pharma Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Dentist Tools, Equipment & Supplies, Oral Care Kit, Nutraceuticals & Dietary Supplements, Mineral Supplement, Industrial Mixers & Homogenizers, Continuous Mixer, Dietary Supplements, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at D R Johns Lab Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramnish Sharma  | CEO | 26-May-2014 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anita Sharma | Director | 01-Jun-2010 | Current |
| Shyam Chandra | Director | 01-Jul-2017 | Current |
Financial Performance of D R Johns Lab Pharma.
D R Johns Lab Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.24% increase. The company also saw a substantial improvement in profitability, with a 119.31% increase in profit. The company's net worth Soared by an impressive increase of 11.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D R Johns Lab Pharma?
In 2023, D R Johns Lab Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 16 Feb 2023 | ₹1.84 M | Open |
Hdfc Bank Limited Creation Date: 10 Aug 2022 | ₹4.09 M | Open |
Hdfc Bank Limited Creation Date: 17 May 2022 | ₹1.77 M | Open |
How Many Employees Work at D R Johns Lab Pharma?
Unlock and access historical data on people associated with D R Johns Lab Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D R Johns Lab Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D R Johns Lab Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
